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Streptomyces bacteria are recognized as an important source for antibiotics with
broad applications in human medicine and animal health. Here, we report the
isolation of a new lichen-associating Streptomyces sp. YIM 130001 from the tropical
rainforest in Xishuangbanna (Yunnan, China), which displayed antibacterial activity
against Bacillus subtilis. The draft genome sequence of this isolate strain revealed
18 putative biosynthetic gene clusters (BGCs) for secondary metabolites, which is an
unusually low number compared to a typical streptomycete. Inactivation of a lantibiotic
dehydrogenase-encoding gene from the BGC presumed to govern biosynthesis of a
thiopeptide resulted in the loss of bioactivity. Using comparative HPLC analysis, two
peaks in the chromatogram were identified in the extract from the wild-type strain, which
were missing in the extract from the mutant. The compounds corresponding to the
identified peaks were purified, and structure of one compound was elucidated using
NMR. The compound, designated geninthiocin B, showed high similarity to several 35-
membered macrocyclic thiopeptides geninthiocin, Val-geninthiocin and berninamycin A.
Bioinformatics analysis of the geninthiocin B BGC revealed its close homology to that of
berninamycins.
Keywords: new Streptomyces sp. from lichen, antibacterial activity, genome mining, new thiopeptide antibiotic,
berninamycins
INTRODUCTION
The successful use of any therapeutic agent is compromised by the potential development of
tolerance or resistance to that compound from the time it is first deployed. This concerns all agents
used in the treatment of bacterial, fungal, parasitic and viral infections, as well as cancer (Davies
and Davies, 2010). Infectious diseases caused by bacteria are among the top causes of mortality in
the world, and if appropriate actions are not implemented, it is estimated that by year 2050 up to 10
million people could die each year because of infections caused by antibiotic resistant pathogens (de
Kraker et al., 2016). A successful curative treatment of such common, yet frequently deadly illnesses,
as pneumonia and tuberculosis, could be soon history, if measures to tackle the antibiotic resistance
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problems are not implemented. Apart from the reduction of
overuse and misuse of antimicrobial agents, identification of new
antibiotics still plays an essential role in controlling bacterial
infections.
The majority of antibiotics used in medicine, veterinary
practice and agriculture originate from actinomycete bacteria,
predominantly from those belonging to the genus Streptomyces
(Barka et al., 2015). Streptomyces are Gram-positive bacteria with
genomes of high GC content, widely distributed in terrestrial
as well as in aquatic ecosystems, and have a complex life
cycle, with a multicellular mycelial growth (Labeda et al.,
2012). Their life cycle starts with the germination of a
spore that grows out to form vegetative hyphae, and further
differentiates from vegetative mycelium into the aerial mycelium.
Morphological differentiation in Streptomyces is an intricately
regulated process, which typically correlates with production of
secondary metabolites (SMs), such as antibiotics (van Wezel and
McDowall, 2011).
Thiopeptide antibiotics are a prominent class of
antimicrobials with potent activity against Gram-positive
bacteria, produced primarily by Streptomyces species (Bagley
et al., 2005). The interest in this family of antibiotics was recently
renewed, since many members of this class show activity against
various drug-resistant pathogens, including methicillin-resistant
Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus
pneumoniae (PRSP), and vancomycin-resistant enterococci
(VRE) (Bagley et al., 2005). Recent success in generation of new
thiopeptide analogs with significantly improved pharmacological
properties may pave the way to the introduction of these types of
compounds in drug development pipelines aimed at antibiotic
resistant pathogens (Just-Baringo et al., 2014).
Thiopeptides belong to the group of ribosomally synthesized
and post-translationally modified peptides (RiPPs) possessing
unique thiazole rings and a six-membered tri-or tetra-substituted
nitrogen heterocycle that can be present in one of the three
oxidation states: a piperidine, dehydropiperidine, or pyridine.
Biosynthesis of thiopeptides follows a relatively straightforward
pathway: a precursor peptide consisting of an N-terminal leader
and a C-terminal core peptide, encoded by a single gene, is
synthesized and undergoes post-translational modifications. All
thiopeptide biosynthetic gene clusters (BGC) contain, in addition
to the gene encoding the precursor peptide, a set of at least
five genes that encode enzymes required for heterocyclization,
dehydration, and the formation of the central six-membered
nitrogen heterocycle (Morris et al., 2009; Burkhart et al.,
2017).
Advances in genetics, genomics and computer science
have changed the way of natural product discovery. The
complete genome sequencing of Streptomyces coelicolor A3(2)
and Streptomyces avermitilis in early 2000s revealed a yet
unexplored biosynthetic potential of the members belonging
to this genus (Bentley et al., 2002; Ikeda et al., 2003) and
led to the idea of genome-guided prediction and isolation
of SMs, the approach known as genome mining (Du and
van Wezel, 2018). Comparison of BGCs encoded in newly
sequenced genomes using software such as antiSMASH (Blin
et al., 2017) helps to identify conserved genes for enzymes
involved in biosynthetic pathways for known classes of
compounds, and thus to predict types of SMs they specify.
In some cases, even the structure of the target SM can
be predicted to a certain extent (Winter et al., 2011). To
make the production, isolation and identification of SM
faster and easier, the genome mining approach is combined
with comparative metabolic profiling (Winter et al., 2011).
Many different techniques contributed to the successful
characterization of new compounds, such as heterologous
expression (Yamada et al., 2015), regulatory genes overexpression
or inactivation (Jiang et al., 2015; Chen et al., 2017), as well
as knock-out of core scaffold-biosynthetic genes (Tian et al.,
2016).
Here, we present the results of a genome mining linked to
the metabolite profiling that led to identification of a new analog
of the thiopeptide antibiotic geninthiocin, geninthiocin B, and
its BGC from a Streptomyces sp. isolated from a lichen. By
combining the classical bioassay-based screening with genome
mining we could rapidly connect the thiopeptide BGC with the
molecule it specifies.
MATERIALS AND METHODS
Isolation and Identification of
Streptomyces sp. YIM 13001
Streptomyces sp. YIM 130001 was isolated from a lichen
Lepidostroma yunnana sp. nov. sample collected format the
tropical rainy forest in Xishuangbanna (Yunnan, China) using
YIM 212 medium (Raffinose 5.0 g, histidine 1.0 g, K2HPO4
1 g, MgSO4·7H2O 0.5 g, Agar 15 g, water to 1 L, pH 7.2∼7.4)
and incubation temperature of 28◦C. Genomic DNA of YIM
130001 was isolated as described below, and used as a template to
PCR-amplify 16S rRNA gene fragment with previously described
primers and protocol (Bredholdt et al., 2007). The resulting
DNA fragment was sequenced, and the sequence deposited in
the GenBank under accession number MH532527. Phylogenetic
analysis of the 16S rDNA sequence was performed using software
MEGA 7.0 (Kumar et al., 2016).
Genome Sequencing and Analyses
The genomic DNA isolation was done from a culture grown
in 50 mL of 3% Tryptone Soya Broth medium (TSB, OXOID,
United Kingdom) inoculated with 50 µL of freshly prepared
spore suspension of YIM 130001 (20% glycerol, v/v) and
incubated in 250 mL baffled flasks at 28◦C, 250 rpm overnight.
The genomic DNA was isolated using Wizard Genomic DNA
Purification Kit (Promega, Madison, WI, United States) as
described previously (Schaffert et al., 2016). For the genome
sequencing, chromosomal DNA was used to generate a TruSeq
PCR-free library that was sequenced on an Illumina MiSeq
system in a 2 × 300 nt run. A total of 348.8 Mbp sequence
data (43.5 × coverage) were assembled using NEWBLER
version 2.8 (Roche), resulting in 59 scaffolds containing 80
contigs. Gene prediction and annotation were performed
with PROKKA SOFTWARE (Seemann, 2014), the relevant
genome features are listed in Supplementary Table S1.
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This Whole Genome Shotgun project has been deposited
at the DDBJ/ENA/GenBank under the accession number
QODG00000000. The version described in this paper is version
QODG01000000.
Generation of Recombinant Bacterial
Strains, Plasmids, and General Growth
Conditions
All routine DNA standard techniques, cloning methods,
and plasmid transformation into Escherichia coli were
performed as described in Sambrook et al. (1989). PCR
fragment amplifications were done with Q5 R© High-Fidelity DNA
Polymerase (New England Biolabs, Ipswich, MA, United States)
using oligonucleotides listed in Supplementary Table S2.
Plasmids and bacterial strains used or constructed during this
study are represented in Supplementary Table S3.
Escherichia coli strains were grown in Luria–Bertani (LB)
broth or on LB agar, supplemented with chloramphenicol
(25 µg mL−1), apramycin (100 µg mL−1), kanamycin
(25 µg mL−1). XL1-blue strain was used for general cloning,
ET12567 (pUZ8002) was used for intergeneric conjugative
transfer of plasmids to Streptomyces as described before (Flett
et al., 1997).
To inactivate the gene genB, a 1055 bps internal fragment from
genB gene was amplified with primers genB_HindIII/genB_EcoRI
primer pair from YIM 130001 genomic DNA and cloned into
the 3.1 kb EcoRI/HindIII fragment of the vector pSOK201
(Supplementary Table S3). The generated plasmid pC1_KN
was transferred into the YIM 130001 strain via conjugation
and resulting genB-distruption mutant (YIM 130001/KN)
was verified by PCR using genB_fwd/genB_rev primer pair
(Supplementary Figure S1C). Wild-type strain YIM 130001
harboring empty vector pSOK804 was used as a control.
Strain Fermentation and Extraction on a
Small-Scale
The production of secondary metabolites by YIM 130001 was
tested in the following liquid media: 5010 (g/L: sucrose 30.0,
NaNO3 2.0, KH2PO4 1.0, MgSO4 × 7 H2O 0.5, KCl 0.5,
FeSO4 × 7 H2O 0.01, pH 7.8): 5288 (g/L: glycerol 15.0, soy meal
10.0, NaCl 5.0, CaCO3 1.0, CoCl2 × 6 H2O 0.001, pH 7.8); 5321
(g/L: peptone 10.0, glucose 20.0, CaCO3 2.0, CoCl2 × 6 H2O
0.001, pH 7.8); 5333 (g/L: yeast extract 4.0, soluble starch 15.0,
K2HPO4 1.0, MgSO4 × 7 H2O 0.5, pH 7.8); and SM17 (Zettler
et al., 2014). Based on the results from bioassay and HPLC,
SM17 medium was chosen as most suitable for the production
of antibacterial compound.
The pre-culture of strains YIM 130001, YIM
130001/pSOK806, and YIM 130001/KN were prepared from
inoculation of 10 mL TSB medium, containing the 50 µg mL−1
apramycin for recombinant strains, with 50 µL of spore-
suspension in 250 mL baffled flasks and cultivation for 24 h
at 250 rpm, 30◦C. Fifty milliliter of SM17 medium without
apramycin was inoculated with 5% of pre-culture and was
cultivated in 250 mL-baffled flasks for 5 days, 250 rpm at 30◦C.
The fermented broth was extracted with 50 mL of butanol
(100%) by 250 rpm, at 30◦C for 2 h. The separation of organic
phase was done via centrifugation at 7000 rpm for 20 min Next,
butanol was removed from the extract by rotor-evaporation at
45◦C, yielding oily crude extract which was dissolved in 1 mL
methanol (100%), filtrated through 0.22◦µm sterile syringe filter
(ThermoFisher Scientific) and used for bioassay and HPLC
analysis.
Bioassay of Antimicrobial Activity
The antibacterial activity of crude extract was tested by disk
diffusion assay. Petri dishes containing 25 mL of nutrient agar
media, depending on the bacterial species, were seeded with
bacterial suspensions from glycerol stock (20% glycerol, v/v).
The sterile Geade AA disk of Whatmann filter (6 mm in
diameter) was impregnated with 15 µL of crude extract in
methanol, dried for 15 min in the sterile bench and placed on
the surface of the seeded agar plate. After 18 h of incubation the
inhibition zone around the disk was measured. The antimicrobial
properties of extracts were tested against Bacillus subtilis, E. coli
XL1 Blue, and Candida albicans ATCC 10231. The strains
B. subtilis and E. coli XL1 Blue, were grown in LB-medium
for preparation of stock solutions (20% glycerol, v/v). The
strain C. albicans ATCC 10231 was grown at 30◦C for 18 h in
M19 liquid medium (for glycerol stock solution, 20 % glycerol,
v/v), or on M19 agar plates for bioassays (Hakvåg et al.,
2008).
Analytical Metabolomics Profiling of
Extracts
Analytical RP HPLC was carried out with an Agilent 1290 HPLC
system equipped with a diode-array UV detector (DAD) at 192–
600 nm, and with the analytical column ZORBAX Eclipse XDB-
C18 4.6 × 150 mm, 5 µm (Agilent). Elution was carried out
with water containing formic acid (0.1%, v/v) as solvent A and
acetonitrile as solvent B, with flow rate of 1 mL/min. The elution
program used was: 0–47.5 min: linear gradient from 5 to 95%
of solvent B, 47.5–50 min: isocratic 100% solvent B, 50–65 min:
isocratic 5% solvent B.
Production of Antimicrobial Compounds
in a Bioreactor
Batch cultivation of YIM 130001 wild type strain was performed
in 3 L bioreactor (BioFlo/CelliGen 115 Fermentor, New
Brunswick Scientific) with a 1.5 L-working volume. The pre-
culture was prepared by inoculation of 10 mL TSB medium
with 50 µL of spore-suspension in 250 mL baffled flasks and
cultivation for 24 h at 250 rpm, 30◦C. Next, two 250 mL baffled
flasks containing 50 mL TSB medium were inoculated with 5% of
pre-culture and cultivated for 48 h at 250 rpm at 30◦C to obtain
the pre-culture for bioreactor inoculation. One point five liter
of SM17 medium in bioreactor were inoculated with 75 mL of
pre-culture and 1 mL of 10% silicone antifoam (stock solution:
30% in H2O, Sigma Aldrich) was added at the start of the
fermentation. The dissolved oxygen level (DO) was kept above
40% using a stirring cascade from 300 to 1000 rpm, aeration
rate from bioreactor was 0.75 vvm. The batch cultivation was
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carried out for 7 days at 30◦C, without controlling pH value and
foam formation in bioreactor. To prevent the foam formation,
additional 1 mL of 10% silicone antifoam solution was added
manually on fermentation days 3 and 5.
Extraction and Purification of
Antimicrobial Compounds
After 7 days of fermentation approximately 1.5 L of whole
fermentation broth with the dry cell mass 58 g L−1 were extracted
with 100% butanol (1:1 v/v), at 30◦C and 250 rpm for 2 h.
The separation of organic phase was done by centrifugation
at 9000 rpm for 20 min. The oily crude extract (14.06 g) was
obtained after removing the solvent in the rotavapor at 45◦C.
To remove the oily substances from the sample, to the crude
extract was supplemented with 200 mL of 100% n-pentane,
the mixture was well stirred and after 2 h of sedimentation at
room temperature, the n-pentane phase was decanted and the
pellet air-dried, yielding 8.06 g of air-dried material. Next, the
pellet was dissolved in 50 mL of 100% methanol. The sample
was purified using flash chromatography by gravity flow with
silica gel 60 (0.063–0.200 mm, 70–230 mesh ASTM, Merck)
as stationary phase. Mobile phases used were: fraction 1, ethyl
acetate (100%), fraction 2, ethyl acetate/methanol (9:1, v/v),
and fraction 3, ethyl acetate/methanol (8:2). All extractions and
purifications steps were tested for bioactivity against B. subtilis
and analytical RP HPLC as describe above. The fraction 2
(ca. 500 mL) showed the activity in the bioassay and the
presence of expected peaks at 22 and 25 min in RP HPLC.
The organic solvents from the fraction 2 were removed in
rotavapor at 45◦C, yielding 125 mg of material, which was
dissolved in 1 mL of 100% methanol and subjected to preparative
HPLC.
Preparative HPLC was carried out with an Agilent 1260 HPLC
system equipped with a DAD and binary pump. Five hundred
microliter of injected sample was separated on preparative
column ZORBAX XDB-C18 21.2 × 150 mm 5 µm (Agilent).
Elution was carried out with water containing formic acid
(0.1%, v/v) as solvent A and acetonitrile as solvent B, with
flow rate of 20 mL/min. The elution program used was:
0–47.5 min: linear gradient from 5 to 95% of solvent B,
47.5–50 min: isocratic 100% solvent B, 50–65 min: isocratic
5% solvent B. The fractions on retention time from 21.8 to
22.2 min (for compound 1) and 25.4–25.8 min (compound
2) were collected and freeze dried. Before freeze drying, the
15 µL of each sample was tested for bioactivity against
B. subtilis.
Flow Injection Analysis – qTOF Mass
Spectrometry
Analyses were performed with an ACQUITY I-class UHPLC
system, operating in flow injection analysis mode (FIA), coupled
to a Synapt G2Si HDMS mass spectrometer (Waters, Milford,
MA, United States) equipped with an ESI source operating in
negative or positive mode.
Flow injection analysis analysis was performed by operating
the UHPLC in bypass, in order to direct the flow passed the
column compartment, and directly to the mass spectrometer.
A mobile phase consisting of 100% methanol was used, and
a linear flow gradient was programmed. The flow rate was
constant at 0.150 mL min−1 for 0.10 min, then reduced to
0.030 min until 1.50 min, then increased to 0.200 mL min−1
until 1.60 min, and finally increased to 0.800 mL min−1
until 1.85 min. The system was equilibrated for additionally
0.25 min at 0.150 mL/min. The total run time was 2.0 min.
The injection volume was set to 2 µL, and needle wash solvent
consisted of 10% water in pure methanol. Sample compartment
was cooled to 10◦C before introducing the sample to the
holder.
Mass spectrometric (MS) analyses were performed under
constant ESI conditions. The capillary voltage, cone voltage
and source offset voltage in negative and positive mode were
set at −2.5 kV/3.0 kV, −30 V/30 V, and −40 V/40 V,
respectively. The source temperature was maintained at 120◦C,
desolvation gas temperature 200◦C, and desolvation gas flow
rate was set at 800 L h−1. The cone gas flow rate was fixed
at 50 L h−1 and the nebulizer gas flow maintained at 6.0
bar. The mass spectrometer was operated in scan mode. The
resolution mode was set to continual high resolution. Scan
time was 0.5 s, and inter-scan delay 0.015 s. Mass range
acquired was 50–2000 Da, the same range as the valid calibration
performed with Na-formate immediately before analysis using
IntelliStart.
During the FIA analysis, a lockmass flow of 10 µL min−1 of
leucine enkephalin (1 ng mL−1) was infused into the ion source
to correct the mass axis on the fly. The lockmass flows from a
separate capillary, and the capillary voltage of this capillary was
set to 2.5 kV (negative or positive, depending on the operation
mode).
UHPLC/FIA–qTOF data were acquired and processed using
MassLynx software (v4.1). Elemental composition and isotope
model features in MassLynx were used for identification.
NMR-Based Structure Elucidation
The sample was prepared by dissolving 1.5 mg of compound
in 160 µL DMSO-d6 (99.9% d) and transferred to a 3 mm
NMR tube. All homo-and heteronuclear NMR spectra were
recorded on a Bruker Ascend 800 MHz Avance III HD NMR
spectrometer (Bruker BioSpin AG, Fälladen, Switzerland)
equipped with 5 mm cryogenic CP-TCI probe. All NMR
spectra were recorded at 25◦C. Shifts were determined
relative to TMS, using the residual DMSO signals for spectra
calibration. For chemical shift assignment of compound,
the following spectra were recorded: 1D 13C, 2D double
quantum filtered correlation spectroscopy (DQF-COSY),
2D rotating-frame nuclear Overhauser effect correlation
spectroscopy (ROESY) with 250 ms mixing time, 2D 13C
heteronuclear single quantum coherence (HSQC) with
multiplicity editing, 2D 13C HSQC-[1H,1H]TOCSY with
70 ms mixing time on protons, 2D heteronuclear multiple bond
correlation (HMBC) with BIRD filter to suppress first order
correlations and 2D 15N HSQC. The spectra were recorded,
processed, and analyzed using TopSpin 3.5 software (Bruker
BioSpin AG, Fälladen, Switzerland). Details on NMR-based
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structure elucidation and recorded NMR spectra are given in
Supplementary Material.
RESULTS AND DISCUSSION
Isolation and Preliminary
Characterization of Streptomyces sp.
YIM 130001
An actinomycete strain YIM 130001 was isolated from the
lichen Lepidostroma yunnana sp. nov., collected at the rainy
forest environment in Xishuangbann, province Yunnan in China.
Based on the phylogenetic analysis analysis, this isolate was
identified as Streptomyces sp. YIM 130001, with closest 16S rDNA
sequence identity (98%) to that of the type strain Streptomyces
malachitospinus NBRC 101004 (Figure 1). The best database
match to the non-type strain was to the endophytic Streptomyces
sp. KLBMP1330 isolated, among other actinomycetes, from the
plant Dendranthema indicum (Linn.) Des Moul collected in East
China (Xing et al., 2014).
The ability of YIM 130001 to produce antimicrobial
compounds was tested by cultivating it in different types of
media and testing culture extracts in bioassays (see “Materials and
Methods” for details). It was shown that the n-butanol extract
from the culture grown in SM17 medium exhibits bioactivity
against B. subtilis, while no effect was shown on the growth of
E. coli and C. albicans.
Analysis of the Streptomyces sp. YIM
130001 Genome
Due to the fact that Streptomyces sp. YIM 130001 appeared to
be phylogenetically diverse from the closest type strain and was
bioactive, we decided to obtain its genome sequence in order
to reveal secondary metabolite biosynthesis potential of this
strain. The high-quality draft genome sequence of Streptomyces
sp. YIM 130001 revealed a single linear chromosome of
8,025,327 bp, with no plasmids, and a G+C content of 70.75%
(see Supplementary Table S1, Supplemental Material, for
additional genome features). Analysis of the YIM 130001 genome
sequence using antiSMASH 4.1.0 software (Blin et al., 2017)
revealed 17 putative BGCs for the biosynthesis of secondary
metabolites (Table 1), which is an unusually low number
compared to a typical streptomycete with a 8-Mb genome. Whole
genome sequencing of multiple Streptomyces species typically
reveals between 25 and 50 BGCs per genome (Katz and Baltz,
2016).
Seven of the clusters identified in YIM 130001 genome
contain genes encoding modular enzymes, such as polyketide
synthases (PKS) and non-ribosomal peptide synthetases (NRPs).
Cluster 17, a PKS type I BGC, was predicted to govern
biosynthesis of a putative enediyene (Table 1). Up to now,
only 12 natural enediyenes were characterized and two of
them are approved as anticancer drugs and at least other
four are in various stages of drug development, making this
compound class attractive for drug discovery (Gredičak and
Jerić, 2007). Cluster 10 was predicted to contain NRPS-encoding
genes, which putative product is a griseobactin/bacillibactin-
like siderophore. Four clusters were annotated as hybrid
BGCs: the putative products from clusters 9 and 11 could
not be predicted, while the BGC 12 has a homology to the
cluster specifying streptogramins biosynthesis. Streptogramin-
like antibiotics occur as two structurally different compounds
that act synergistically to inhibit ribosomal peptidyl transfer
during bacterial protein biosynthesis, while separately they
exhibit only moderate antibacterial activity (Di Giambattista
et al., 1989). antiSMASH initially predicted cluster 14 as being
of terpene-NRPS hybrid type. However, closer inspection using
BLAST and genetic context suggested that this locus is likely to
comprise two separate BGCs, 14a for a carotenoid, and for 14b
non-ribosomally synthesized peptide (Table 1).
In addition to the PKS- and NRPS- containing gene clusters,
three BGCs for terpenoid biosynthesis were identified, one of
them presumably responsible for hopanoids synthesis (Table 1).
Hopanoids have a condensing effect on biological membranes
due to their rigid ring structures, which help to stabilize the
membranes once integrated. In S. coelicolor hopanoids are
synthesized during formation of aerial hyphae to alleviate stress
FIGURE 1 | Molecular phylogenetic analysis of 16S rRNA gene fragments of Streptomyces sp. YIM 130001 and related species by Maximum Likelihood method.
The evolutionary history was inferred by using the Maximum Likelihood method based on the Hasegawa-Kishino-Yano model. Evolutionary analyses were conducted
in MEGA7 (19).
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TABLE 1 | Secondary metabolite BGCs in Streptomyces sp. YIM 130001
predicted with antiSMASH 4.1.0 followed by manual curation with Protein BLAST
and MIBiG algorithms.
Cluster
no.
Cluster type Best database
cluster hit
Putative product
1 Thiopeptide Streptomyces
atroolivaceus NRRL
ISP-5137
Geninthiocin B
2 T3pks no plausible hits Polyketide
3 Terpene no plausible hits Terpenoid
4 Terpene Streptomyces
mobaraensis NBRC
13819
Geosmin
5 Ectoine Streptomyces
anulatus
Ectoine
6 Bacteriocin Streptomyces
turgidiscabies Car8
Bacteriocin-like
7 Bacteriocin no plausible hits Bacteriocin-like
8 Bacteriocin no plausible hits Likely false
9 T1pks-Otherks Streptomyces
albus BK3-25
Polyketide,
glycosylated
10 Nrps Many
Streptomyces spp.
Griseobactin/
Bacillibactin-
likesiderophore
11 Nrps-Linaridin no plausible hits NRPS-PKS hybrid
product
12 T3pks-Transatpks-
Terpene-Otherks-
Nrps
Streptomyces sp.
CB01635
Streptogramins
13 Terpene Streptomyces sp.
Root55
Hopene
14a 14b Terpene Nrps Streptomyces
phaeoluteigriseus
Streptomyces sp.
Wb2n-11
Isorenieratene NRS
peptide
15 Siderophore Many
Streptomyces spp.
Acinetoferrins
16 Lassopeptide Many
Streptomyces spp.
Putative Class II
lasso peptide
17 T1pks Streptomyces sp.
CB02414
Enediyne
in aerial mycelium by diminishing water permeability across
the membrane (Poralla et al., 2000). Cluster 16 was predicted
to encode a putative lassopeptide, whereby manual inspection
with Protein BLAST and MIBiG algorithms showed similarity
to BGCs in many Streptomyces spp. The genes from cluster 15
showed high similarity (59–93%) to the genes from many other
Streptomyces spp. that encode putative siderophore actinoferrin
involved in iron acquisition (Sandy and Butler, 2009). A likely
product from cluster 5 was predicted as ectoine, its BGC has
high similarity with its counterpart in Streptomyces anulatus.
Ectoines are most commonly found osmolytes in Streptomyces
and help microorganisms to cope with osmotic stress (Sadeghi
et al., 2014). Three BGCs were predicted to encode bacteriocins-
like compounds. These clusters showed high similarity to other
conserved clusters, the metabolic products of which are not
known. Cluster 8, due to sequence gaps within the genome, was
likely falsely annotated as a BGC (Table 1). The cluster 1 was
predicted by antiSMASH software as a thiopeptide BGC, and
after the manual Protein BLAST search, its high homology to the
berninamycin gene cluster (Malcolmson et al., 2013) was noticed.
Analysis of Thiopeptide BGC and
Identification of the Cognate Bioactivity
Among the clusters identified in the Streptomyces sp. YIM
130001 genome, cluster 1 was predicted by antiSMASH to
specify biosynthesis of a thiopeptide, and manual inspection of
encoded gene products using BLAST predicted that it could
yield a berninamycin-like analog (Table 1). Due to the fact
that the members of thiopeptide family are known for their
antimicrobial activities against Gram-positive bacteria (Just-
Baringo et al., 2014), we assumed that the product of cluster
1 might be responsible for the activity against B. subtilis in
crude extract. In order to investigate this, genB gene encoding
a putative lantibiotic dehydratase (Table 2) was inactivated
via insertion of the pC1_KN vector into its coding region,
yielding recombinant strain YIM 130001/KN. The correct
insertion of the knock-out vector was subsequently confirmed by
PCR (Supplementary Figure S1, Supplemental Material). The
crude butanol extract from recombinant strain YIM 130001/KN
was tested for antibacterial activity against B. subtilis and its
metabolite profile was analyzed with analytical RP-HPLC in
comparison with a butanol extract from the wild-type strain
(Figure 2). YIM 130001/KN-extract, in contrast to that from
the wild-type strain, failed to exhibit antibacterial activity against
B. subtilis. Furthermore, using comparative analytical RP-HPLC
it was shown that in the extract of YIM 130001/KN strain
two chromatographic peaks at ca 22 and 25 min disappeared
(Figure 2), indicating that those two peaks might correlate with
both the antibacterial activity and the cluster 1 product.
Purification and Structure Elucidation of
Bioactive Compounds Produced by
Streptomyces sp. YIM 130001
An up-scaled fermentation of YIM 130001 in medium SM17,
followed by multiple steps of silica gel and preparative C-
18 chromatography (see “Materials and Methods” for details),
afforded two compounds, compound 1 (1.5 mg) and compound 2
(0.1 mg), both with antibacterial activities against B. subtilis (data
not shown). During this study, the optimal conditions to elicit
production of compound 2 were not developed, and a sufficient
amount could not be purified to perform a proper MS/MS
analyses or structure elucidation via NMR. The molecular
masses of compounds 1 and 2 were determined on the basis
of qTOF mass spectrometry, that afforded the masse-to-charge
ratios of 1062.2965 m/z and 1046.3030 m/z (1061.2965 m/z and
1045.3030 m/z in negative mode, Supplementary Figure S2),
respectively.
The NMR structure elucidation of compound 1 showed
clearly that the molecule contained a free primary amido-group
(N-56, Supplementary Figure S3) and eight peptide bonds
(Supplementary Table S4). In addition, five terminal double
bonds indicated five didehydroalanine residues. Threonine
residue, didehydrobutyrine and hydroxy valine were also easily
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TABLE 2 | Deduced functions of ORFs in and around the geninthiocin B biosynthetic gene cluster.
Gene no. Size of proteina Protein homolog and its source Accessions number Identity (%) Proposed function
orf 1 1304 β’-subunit DNA-directed RNA
polymerase; Streptomyces scopuliridis
WP_030351424.1 97 Transcription of DNA into RNA
orf 2 149 N-acetyltransferase; Streptomyces
eurocidicus
WP_102917203.1 71 Transfer of acetyl groups from
acetyl-CoA
orf 3 123 S12; Many Streptomyces sp. WP_007265893.1 99 30S ribosomal protein
orf 4 156 S7; Streptomyces tsukubensis WP_077968976.1 99 30S ribosomal protein
orf 5 706 EF-G; Streptomyces rapamycinicus
NRRL 5491
AGP55834.1 93 Elongation factor
orf 6 397 EF-Tu; Streptomyces tsukubensis WP_077968978.1 98 Elongation factor
genE1 234 hypothetical protein
SAMN05444921_112167;
Streptomyces wuyuanensis
SDM72766.1 76 Thiazoline dehydrogenase
genE2 543 TpaE; Streptomyces wuyuanensis WP_093656415.1 71 Thiazoline dehydrogenase
genG1 212 hypothetical protein; Streptomyces
atroolivaceus
WP_051709133.1 71 Bacteriocin biosynthesis
cyclodehydratase domain
genG2 448 hypothetical protein; Streptomyces
atroolivaceus
WP_051709136.1 82 Thiazole-forming peptide maturase
genD 357 BerD; Streptomyces bernensis AGN11669.1 61 Putative pyridine-forming enzyme
genA 46 thiocillin/thiostrepton family thiazolyl
peptide; Streptomyces wuyuanensis
WP_094030676.1 86 Geninthiocin B structural gene
genB 885 hypothetical protein; Streptomyces
atroolivaceus
WP_051709141.1 78 Lanthibiotic dehydratase N-terminus
genC 320 hypothetical protein; Streptomyces
atroolivaceus
WP_078597759.1 76 Lanthibiotic dehydratase C-teminus
genH 400 cytochrome P450; Streptomyces
atroolivaceus
WP_033297595.1 83 Cytochrome P450
genI 114 hypothetical protein; Streptomyces
wuyuanensis
WP_093656403.1 86 C-terminal amide-forming enzyme
orf 7 102 S10; Many Streptomyces sp. WP_014054162.1 100 30S ribosomal protein
orf 8 214 L3; Streptomyces varsoviensis WP_030890763.1 98 50S ribosomal protein
orf 9 215 L4; Streptomyces indicus WP_093613746.1 94 50S ribosomal protein
orf 10 106 L23; Streptomyces indicus WP_093613748.1 96 50S ribosomal protein
aNumbers refer to amino acid residues.
identifiable. Identification of cyclic structures of thiazol, oxazol,
and pyridine rings were somewhat more challenging because of
relatively large number of non-protonated carbons/heteroatoms
and distant protons. By combining data from DQF-COSY,
HMBC, HSQC, ROESY, and 15N-HSQC, the connectivity
between the previously identified fragments was established.
Protons from two OH groups could not be detected and assigned,
probably because of their strong involvement in H-bonding.
The shift assignments of 1H, 13C, and 15N (protonated) are
shown in Supplementary Table S4. Based on NMR results,
the molecular formula of compound 1 was determined as
C47H46N14O14S, and the elucidated chemical structure indicated
it closely resembles thiopeptide geninthiocin (Yun et al., 1994),
albeit differing from the latter at the C-terminal part (Figure 3).
Consequently, compound 1 was designated as geninthiocin B.
The scaffolds from geninthiocin-like thiopeptides (geninthiocin
and val-geninthiocin) are very similar to berninamycins (e.g.,
berninamycin A), which differ by one additional methyl-
group on the oxazol ring (Figure 3). At the same time,
geninthiocin B differs from two up to now characterized
geninthiocins (Yun et al., 1994; Sajid et al., 2008) in lacking one
Dha-residue on its C-terminus tail region. The macrocycle of
newly discovered geninthiocin B is 35-membered, and because
of its tri-substituted pyridine ring, it belongs to the series d
thiopeptides (Just-Baringo et al., 2014).
Analysis of the Geninthiocin B
Biosynthesis Gene Cluster
The geninthiocin B biosynthesis gene cluster spans ca. 23.4 kb
and contains 20 open reading frames (Table 2, Figure 4).
BLAST analysis of this thiopeptide BGC showed similarity
to Streptomyces atroolivaceus and Streptomyces wuyuanensis
uncharacterized clusters. Its genes, especially their organization,
were predicted to have a similarity to the BGC for berninamycin
biosynthesis (Figure 4, Malcolmson et al., 2013). However,
the comparison of the GenA core peptide sequence showed
a closer similarity to geninthiocin isolated from Streptomyces
sp. DD84 (Yun et al., 1994) and val-geninthiocin, originated
from Streptomyces sp. RSF18 (Sajid et al., 2008). Up to
now, only a few thiopeptides with 35-membered macrocycles
have been described: geninthiocin, berninamycin, sulfomycin
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FIGURE 2 | Comparative RP-HPLC chromatogram at 254 nm of the crude extracts from Streptomyces sp. YIM 130001 wild type (WT, in blue) and the strain YIM
130001/KN with deactivated genB gene (KN, in red), with corresponding bioassay against B. subtilis.
FIGURE 3 | Chemical structures of the newly isolated geninthiocin B and its analogs berninamycin A, geninthiocin, and val-geninthiocin.
(Abe et al., 1988), thioplabin (Ohyama et al., 2002), and TP-
1161 (Engelhardt et al., 2010a), and respective BGCs were
reported for TP-1161 and berninamycin (Engelhardt et al., 2010b;
Malcolmson et al., 2013). The newly isolated geninthiocin B is
another member of this thiopeptide group and its identified BGC
helps to understand its biosynthesis based on the homology to
that of berninamycin (Figure 4).
Burkhart et al. (2017) suggested that due to the structural
similarity between geninthiocin and berninamycin, the
biosynthesis of those two compounds is likely to be very
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FIGURE 4 | The biosynthetic gene clusters for berninamycin A and the newly isolated geninthiocin B (A), with their precursor peptide sequences (B), encoded by
the structural genes. In the precursor peptide sequence, the core peptide appears in the mature thiopeptide, while the leader peptide sequence is removed during
posttranslational modification.
similar. In silico prediction of enzymatic functions of individual
gene products from genenthiocin B BGC allowed us to propose
the biosynthesis of geninthiocin B (Supplementary Figure S4).
The geninthiocin B structural gene (genA) encodes a 31-aa leader
peptide linked to a C-terminal 15-aa core (Figure 4). Ten amino
acids of the core peptide are represented by serine, whereby Ser15
is absent in the mature scaffold (Figure 3). The cleavage of Ser15
is needed to afford the C-terminus amide, and is presumably
catalyzed by GenI, which is homologous to the NocA and NosA
enzymes from nocathiacin and noshipeptide biosynthesis. It
has been shown that NosA acts on an intermediate bearing
a bis-dehydroalanine tail in noshipeptide and catalyzes an
enamide dealkylation to remove the acrylate unit originating
from the extended serine residue (Yu et al., 2010; Wang et al.,
2015).
As in the berninamycin BGC, the unique feature of
geninthiocin B cluster is that its genes for cyclodehydratase
and dehydrogenase (most likely responsible for the formation
of thiazole/oxazole rings), are split in a non-traditional way
(Figure 4). The geninthiocin B biosynthesis YcaO “G” protein
is split into GenG1/GenG2 and the protein “E” is split into
GenE1/GenE2. The protein GenE2 probably has the partner
function of the so-called E1-like proteins, which interact with
a side chain of the leader peptide and promote GenG1 and
GenG2 to perform the d cyclodehydration. In earlier studies
it was observed that E1-like partner protein is required for
substrate guiding and recognition by YcaO protein (Burkhart
et al., 2015), as well as playing a crucial role in allosteric activation
of the latter (Dunbar et al., 2012, 2014). This partner protein
can either be represented by a discrete polypeptide or fused to
the YcaO (Burkhart et al., 2017). Similarly to the berninamycin
BGC, unusual is an appearance of the canonical E1-like protein
fused to a dehydrogenase (GenE2), as well as the presence of
another dehydrogenase component (GenE1) encoded by the
gene near genE2. Due to this atypical genetic organization, it
is unclear how the active azole-forming proteins function with
each other. Burkhart et al. (2017) suggested that these proteins
might catalyze the formation of a large 35-member macrocycle,
since the spacing of azole/azoline heterocycles in the macrocycle
region of berninamycin is nearly identical to that of the thiocillin-
like thiopeptides, which have a 26-membered macrocycle after
maturation.
Proteins GenB and GenC (Table 2) showed high similarity
to lanthipeptide-like dehydratases and most likely catalyze the
formation of the dehydroalanine (Dha) and dehydrobutyrine
(Dhb) functional groups. Reconstitution studies using purified
enzymes have established both the nature and the timing
of the modifications installed during the biosynthesis of the
thiopeptide antibiotic thiomuracin in Thermobispora bispora
(Zhang et al., 2016). It was shown that after formation of the
Dha residues, the central six-membered nitrogenous heterocycle
is assembled via a formal [4+2] cycloaddition between the two
Dha groups (Zhang et al., 2016). We suggest that in geninthiocin
B biosynthesis the serine Ser1 and Ser13 are the key amino acids
in the final macrocycle formation (Figure 4). GenD protein
showing high degree of similarity to BerD from berninamycin
pathway, which was predicted to catalyze the formation of
characteristic for thiopeptides series d tri-substituted pyridine
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ring, is most probably also involved in the macrocycle formation
(Malcolmson et al., 2013).
The gene genH (Figure 4, Table 2) encodes a homolog of BerH
from berninamycin BGC, a putative P450 hydroxylase family
protein that is most probably involved in valine hydroxylation
(Malcolmson et al., 2013). The characterization of two P450
cytochrome-like proteins of nosiheptide (NosB and NosC) in
Streptomyces actuosus ATCC 25421 indicated that those are
responsible for hydroxylation occurring most likely at the
tailoring stage, after the main scaffold is formed (Liu et al.,
2013). During this work we could detect two compounds:
geninthiocin B and an uncharacterized compound 2, both
products from the geninthiocin B gene cluster. Based on
the high-resolution LC-MS analysis, the compound 2 differs
from geninthiocin B by one oxygen atom (Supplementary
Figure S2). We suggest that compound 2 has similar structure to
geninthiocin B, but lacks a hydroxyl group on Val7-residue. The
appearance of a thiopeptide intermediate is not surprising and
was described before for berninamycin (berninamycins A and B)
(Lau and Rinehart, 1994). Moreover, a desoxygeninthiocin (val-
geninthiocin) was isolated from Streptomyces sp. RSF18, which
has a similar structure as geninthiocin, but lacks a hydroxyl-
group on Val7-residue. If our assumption for structural features
of compound 2 is correct, it can be produced as a major
metabolite from the geninthiocin B cluster upon inactivation
of the genH gene. The overall yield of geninthiocin B-related
compounds must be improved to allow for more detailed
studies on these molecules. The latter can be achieved either
via heterologous expression of the cluster in an engineered
Streptomyces host (Myronovskyi et al., 2018), or re-factoring of
the cluster in YIM 130001 via promoter replacement (Horbal
et al., 2018).
Geninthiocin B gene cluster is flanked at both ends by the
genes encoding ribosomal and translation-associated proteins
(Figure 4, Table 2), which are presumably not involved in
geninthiocin B and compound 2 biosynthesises, but may play
a key role in self-resistance of Streptomyces sp. YIM 130001.
Berninamycin, which like genintiocin B also possesses a 35-
membered macrocycle, is known to target 50S ribosomal
subunit by binding to the 23S/L11 complex, thereby inhibiting
protein synthesis (Reusser, 1969; Thompson et al., 1982). The
mechanisms of self-resistance to 35-membered macrocyclic
thiopeptides are still not completely understood (Just-Baringo
et al., 2014), but for the berninamycin-producing Streptomyces
bernensis it was shown that its respective BGC contains a gene
encoding ribosomal RNA methylase. These proteins catalyze
specific methylation of ribose on the 23S ribosomal RNA,
preventing binding of thiopeptides to the modified ribosomes
(Thompson et al., 1982). No genes encoding putative ribosomal
RNA methylase could be identified in the geninthiocin B gene
cluster or its flanking regions, suggesting that self-resistance in
YIM 130001 may be achieved via different mechanism. This may
also imply that the molecular target of geninthiocin B is different
from that of berninamycin, despite very close similarity between
their chemical structures and the same size of the macrocycle.
It has been speculated that some thiopeptides, including
thiostreptone commonly used in veterinary medicine and
research, may also serve at sub-inhibitory concentrations as
signal molecules for physiological development or quorum-
sensing in bacteria (Holmes et al., 1993). Keeping in mind
the fact that thiopeptides at higher concentration have strong
antibacterial activity (Bagley et al., 2005), a likely other ecological
function of geninthiocin B could be defense against predatory
bacteria and/or means of competition for nutritional sources.
CONCLUSION
Streptomycetes are characterized by a complex metabolism and
their ability to produce diverse types of antibiotics. In this work
we describe the identification of new thiopeptide antibiotic,
geninthiocin B, from Streptomyces sp. YIM 130001 with
bioactivity against B. subtilis. Combined analysis of the genome
sequencing data and metabolite profiling led to identification of
geninthiocin B gene cluster, confirming the power of genome
mining approach in the natural product discovery process.
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